OptimizeRx (OPRX) Proxy Filing summary

Executive summary

• Confirmed receipt of a stockholder's notice to nominate two candidates for election to the board at the 2025 Annual Meeting.

• Board will provide a formal recommendation on director nominations in the definitive proxy statement before the meeting.

• Forward-looking statements highlight risks including regulation, technology changes, cybersecurity, and customer concentration.

Voting matters and shareholder proposals

• Stockholder Whetstone Capital Advisors, LLC intends to nominate two candidates for board election at the 2025 Annual Meeting.

• No immediate stockholder action is required; further details will be provided in the definitive proxy statement.

Board of directors and corporate governance

• The board will review and make a formal recommendation regarding the director nominations in the upcoming proxy statement.

• Information on board participants and their interests will be disclosed in the proxy statement and related SEC filings.